FI940097A0 - Method for preparing starch esters for clinical, especially parenteral use - Google Patents

Method for preparing starch esters for clinical, especially parenteral use

Info

Publication number
FI940097A0
FI940097A0 FI940097A FI940097A FI940097A0 FI 940097 A0 FI940097 A0 FI 940097A0 FI 940097 A FI940097 A FI 940097A FI 940097 A FI940097 A FI 940097A FI 940097 A0 FI940097 A0 FI 940097A0
Authority
FI
Finland
Prior art keywords
starch esters
mole
carbon atoms
clinical
range
Prior art date
Application number
FI940097A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI940097A (en
Inventor
Harald Foerster
Fatima Asskali
Ernst Nitsch
Original Assignee
Laevosan Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laevosan Gmbh & Co Kg filed Critical Laevosan Gmbh & Co Kg
Publication of FI940097A0 publication Critical patent/FI940097A0/en
Publication of FI940097A publication Critical patent/FI940097A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/02Esters
    • C08B31/04Esters of organic acids, e.g. alkenyl-succinated starch
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B35/00Preparation of derivatives of amylopectin
    • C08B35/02Esters

Abstract

In order to prepare physiologically tolerated water-soluble starch esters, the invention proposes that starch is converted by acid hydrolysis or enzymatic hydrolysis to a partially hydrolysed form with a mean molecular weight in the range from 10,000 to 500,000 Daltons. This partial hydrolysate is then acylated, in aqueous solution, with the anhydride or halide of an aliphatic monocarboxylic acid with 2 to 4 carbon atoms or an aliphatic dicarboxylic acid with 3 to 6 carbon atoms, or mixtures thereof, and an alkalinization agent, to give a product with a substitution ratio in the range from 0.1 to 1.0 mole/mole. Salts are removed from the resulting reaction mixture. The starch esters thus obtained are highly suited for clinical use, in particular parenteral administration and administration in the diet.
FI940097A 1991-07-11 1994-01-10 Method of preparation for starch esters used clinically, especially parenterally FI940097A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4123000A DE4123000A1 (en) 1991-07-11 1991-07-11 METHOD FOR PRODUCING STARCHESTERS FOR CLINICAL, IN PARTICULAR PARENTERAL APPLICATION
PCT/EP1992/001553 WO1993001217A1 (en) 1991-07-11 1992-07-09 Method of preparing starch esters for clinical, in particular parenteral, applications

Publications (2)

Publication Number Publication Date
FI940097A0 true FI940097A0 (en) 1994-01-10
FI940097A FI940097A (en) 1994-01-10

Family

ID=6435928

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940097A FI940097A (en) 1991-07-11 1994-01-10 Method of preparation for starch esters used clinically, especially parenterally

Country Status (17)

Country Link
EP (1) EP0593605B1 (en)
JP (1) JPH06511506A (en)
AT (1) ATE160576T1 (en)
AU (1) AU656014B2 (en)
CA (1) CA2113162A1 (en)
CZ (1) CZ5994A3 (en)
DE (2) DE4123000A1 (en)
DK (1) DK0593605T3 (en)
ES (1) ES2112323T3 (en)
FI (1) FI940097A (en)
GR (1) GR3025927T3 (en)
HU (1) HUT72587A (en)
PL (1) PL170733B1 (en)
PT (1) PT100679B (en)
RU (1) RU2093522C1 (en)
SK (1) SK279878B6 (en)
WO (1) WO1993001217A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4123001A1 (en) * 1991-07-11 1993-01-14 Laevosan Gmbh & Co Kg PHARMACEUTICAL COMPOSITION FOR PERITONEAL DIALYSIS
DE4122999A1 (en) * 1991-07-11 1993-01-14 Laevosan Gmbh & Co Kg METABOLIZABLE PLASMA REPLACEMENT
DE4242926C2 (en) 1992-12-18 1994-12-15 Fresenius Ag Dialysis solution for peritoneal dialysis
FI942686A0 (en) * 1994-06-07 1994-06-07 Alko Ab Oy Composition of the starch acetate with a variety of compounds, for the production and distribution
DE4442605A1 (en) * 1994-11-30 1996-06-05 Degussa Swellable starch ester, process for its production and use
DE4442606C2 (en) * 1994-11-30 1998-09-17 Degussa Swellable starch ester, process for its production and use
US7772391B2 (en) 2005-06-16 2010-08-10 The Procter & Gamble Company Ethersuccinylated hydroxyl polymers
DE102010012183A1 (en) * 2010-03-19 2011-09-22 Fresenius Medical Care Deutschland Gmbh Esterified polysaccharide osmotica
WO2016137751A1 (en) 2015-02-24 2016-09-01 The Procter & Gamble Company Process for molecular weight reduction of ethersuccinylated polysaccharides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2362282A (en) * 1942-09-12 1944-11-07 Wesley N Lindsay Method of acetylating starch
US2363382A (en) * 1943-08-27 1944-11-21 Charles W Attwood Scaffolding
US3639389A (en) * 1968-05-15 1972-02-01 Cpc International Inc Low d.e. starch hydrolysate derivatives
GB1476057A (en) * 1975-03-20 1977-06-10 Unicliffe Ltd Throat pastilles

Also Published As

Publication number Publication date
SK279878B6 (en) 1999-05-07
JPH06511506A (en) 1994-12-22
ATE160576T1 (en) 1997-12-15
DE4123000A1 (en) 1993-01-14
WO1993001217A1 (en) 1993-01-21
PT100679A (en) 1993-09-30
DK0593605T3 (en) 1998-08-10
ES2112323T3 (en) 1998-04-01
PT100679B (en) 1999-09-30
CZ5994A3 (en) 1994-07-13
EP0593605B1 (en) 1997-11-26
EP0593605A1 (en) 1994-04-27
PL170733B1 (en) 1997-01-31
RU2093522C1 (en) 1997-10-20
SK2394A3 (en) 1994-08-10
HU9400064D0 (en) 1994-05-30
AU656014B2 (en) 1995-01-19
FI940097A (en) 1994-01-10
GR3025927T3 (en) 1998-04-30
HUT72587A (en) 1996-05-28
AU2277592A (en) 1993-02-11
CA2113162A1 (en) 1993-01-21
DE59209043D1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
FI940097A0 (en) Method for preparing starch esters for clinical, especially parenteral use
AU3492789A (en) Pharmaceutical compositions
TW225568B (en)
GB1402069A (en) Process for the preparation of mixed partial esters of carbohydrates
RU94016156A (en) METHOD FOR OBTAINING COMPLEX STARTER ETHERS FOR CLINICAL, ESPECIALLY PARENTERAL, APPLICATIONS
HU9400066D0 (en) Process for preparing a pharmaceutical comp. to peritoneal dyalisis
SU802290A1 (en) Method of preparing carboxyl-containing chitosan derivatives
AU1973188A (en) Process for preparing halogenated imides and their application as flame-retardant agents
KR850004572A (en) Dialkanoyloxybenzylidene dialkanoate
IL118038A (en) 7-((2-carboalkoxy-1-methylethenyl) amino)-3-hydroxymethyl-3-cephem-4-carboxylic acids and process for their preparation
GB561104A (en) Manufacture of ester-amide polymers
ES2077225T3 (en) PROCEDURE FOR THE PREPARATION OF EQUIMOLAR SALTS OF DIVALENT METAL O-AMIN-DICARBOXYLIC ACIDS.
TH13802A (en) Helps to produce tiny wrinkles based on methylbisic (3-aminopropylamine) polyamide
TH13802EX (en) Helps to produce tiny wrinkles based on methylbis (3-aminopropylamine) polyamide